Because of Jeff's personal experience with this medical innovation, he believes it can change the world: "it's an incredible brand-new pattern in medicine driven by innovation that spotted cancer. And offered me a battling opportunity to beat it very early before it turned into a possibly deadly issue." Jeff does not simply suggest investing in this business to profit from this pattern.
: "But there's more to this technology than just saving my life. By subscribing to The Near Future Report today, you can discover how this technology works, what it does, and why Jeff thinks it will alter the world of medication.
Jeff Brown uses Mirati Therapeutics as an example, which rose 8,481% in under two years. Other gains featured on The Near Future Report's sales page consist of: Jeff Brown is careful to describe that past incomes do not ensure future results.
He does not advise allocating a substantial part of your portfolio to these stocks. However, Jeff also declares he has "visited providers and done his own research on future revenues" to confirm his suggestions. Based on that analysis, Jeff is positive that some of his biotech stock picks will increase significantly in the future.
2 Trillion Industry that Could Save Millions of Lives? Jeff, like many investors, thinks biotech will be one of the hottest tech trends over the coming years. Biotech is no trick.
Jeff mentions accuracy medication as one example: "the biotech market is expected to grow 86% over the next few years. That is outstanding. But listen to this, The accuracy medicine market is anticipated to grow 152% during that same time" Accuracy medicine is an emerging location of biotech that utilizes exact biological information to calculate illness risk.